This study is not accepting new patients
Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study start
- Principal Investigator
- by Brian Schwartz
Description
Summary
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Brian Schwartz
Brian Schwartz is a physician specializing in the treatment of infectious diseases, specifically the diagnosis, treatment, and prevention of infections in immunocompromised patients. He serves as the Associate Chair of Education for the Department of Medicine.
Details
- Status
- not accepting new patients
- Start Date
- Sponsor
- University of California, San Francisco
- ID
- NCT00508963
- Study Type
- Expanded Access
- Last Updated